CHRISTINE OBERG: Open Payments
NPI 1194061788 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 26 payments from 12 companies in 2025. Trend: 2023 $870 · 2024 $834 · 2025 $721
Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 4 | $280 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $122 |
| Amgen Inc. | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Aurinia Pharma U.S., Inc. | 2 | $40 |
| Ardelyx, Inc. | 1 | $33 |
| Novo Nordisk Inc | 1 | $19 |
| Vifor Pharma, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: Vafseo, Kerendia, KRYSTEXXA, FARXIGA, JYNARQUE, LUPKYNIS, IBSRELA, Ozempic.
Industry payments across NM — which companies pay providers there.
